How an Activist Group Helped Torpedo MDMA Therapy
Health
By Andrew Jacobs and Rachel Nuwer from NYT Health https://ift.tt/Rz9ZHik
via IFTTT Regulation and Deregulation of Industry, Psychedelic and Hallucinogenic Drugs, Ethics and Official Misconduct, Therapy and Rehabilitation, Veterans, Clinical Trials, Mental Health and Disorders, Psychiatry and Psychiatrists, Post-Traumatic Stress Disorder, Research, Drugs (Pharmaceuticals) The fallout from the F.D.A.’s rejection of a new treatment for PTSD worries researchers and experts who fear other psychedelic drugs in the pipeline could be jeopardized.

By Andrew Jacobs and Rachel Nuwer from NYT Health https://ift.tt/Rz9ZHik
via IFTTT Regulation and Deregulation of Industry, Psychedelic and Hallucinogenic Drugs, Ethics and Official Misconduct, Therapy and Rehabilitation, Veterans, Clinical Trials, Mental Health and Disorders, Psychiatry and Psychiatrists, Post-Traumatic Stress Disorder, Research, Drugs (Pharmaceuticals) The fallout from the F.D.A.’s rejection of a new treatment for PTSD worries researchers and experts who fear other psychedelic drugs in the pipeline could be jeopardized.
Comments
Post a Comment